Working… Menu

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer (SOPHIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02492711
Recruitment Status : Active, not recruiting
First Posted : July 9, 2015
Last Update Posted : October 19, 2021
Information provided by (Responsible Party):